Abstract
Periodontitis, which is a chronic inflammatory disease caused by oral bacterial infection, is considered to be a risk factor for systemic disease. The liver is an important organ closely associated with lipid and glucose metabolism. Non-alcoholic fatty liver disease (NAFLD) is a major chronic liver disease. In this chapter, the relationship between periodontitis and liver diseases, focusing mainly on NAFLD progression, is summarized. Periodontitis increases the serum lipopolysaccharide level, contributing to liver injury. In addition, clinical and animal studies have shown that periodontal inflammation induces overproduction of lipid peroxide in the periodontal lesion, which is involved in progression of liver diseases. That liver abnormalities may indicate a risk for periodontitis and that periodontitis may be a risk factor for the progression of liver diseases are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Williams RC (1990) Periodontal disease. N Engl J Med 322:373–382
Meley BL, Oates TW (2006) American academy of periodontology: diabetes mellitus and periodontal diseases. J Periodontol 77:1289–1303
Cutler CW, Iacopino AM (2003) Periodontal disease: links with serum lipid/triglyceride levels? Review and new data. J Int Acad Periodontol 5:47–51
Morrison HI, Ellison LF, Taylor GW (1999) Periodontal disease and risk of fatal coronary heart and cerebrovascular diseases. J Cardiovasc Risk 6:7–11
Sculley DV, Langley-Evans SC (2002) Salivary antioxidants and periodontal disease status. Proc Nutr Soc 61:137–143
Valko M, Leibfritz D, Moncol J, Gronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human diseases. Int J Biochem Cell Biol 39:44–84
Cahill A, Wang X, Hoek JB (2004) Increased oxidative damage to mitochondrial DNA following chronic ethanol consumption. Alcohol 235:49–58
Ekuni D, Tomofuji T, Sanbe T, Irie K, Azuma T, Maruyama T, Tamaki N, Murakami J, Kokeguchi S, Yamamoto T (2009) Vitamin C intake attenuates the degree of experimental atherosclerosis induced by periodontitis in the rat by decreasing oxidative stress. Arch Oral Biol 54:495–502
Panjamurthy K, Mannoharan S, Ramachandran CR (1999) Lipid peroxidation and antioxidant status in patients with periodontitis. Cell Mol Biol Lett 10:255–264
Sobaniec H, Sobaniec-Lotowska ME (2000) Morphological examinations of hard tissues of periodontium and evaluation of selected processes of lipid peroxidation in blood serum of rats in the course of experimental periodontitis. Med Sci Monit 6:875–881
Butterfield DA, Bader Lange ML, Sultana R (2010) Involvement of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer’s disease. Biochim Biophys Acta 1801:924–929
Singh M, Nam DT, Arseneault M, Ramassamy C (2010) Role of by-products of lipid oxidation in Alzheimer’s disease brain: a focus on acrolein. J Alzheimers Dis 21:741–756
Davies SS, Roberts LJ 2nd (2011) F2-isoprostanes as an indicator and risk factor for coronary heart disease. Free Radic Biol Med 50:559–566
Wiswedel I, Hirsch D, Carluccio F, Hampl H, Siems W (2005) F2-isoprostanes as biomarkers of lipid peroxidation in patients with chronic renal failure. Biofactors 24:201–208
Poli G, Biasi F, Leonarduzzi G (2008) 4-Hydroxynonenal-protein adduct: a reliable biomarkers of lipid oxidation in liver diseases. Mol Aspects Med 29:67–71
Saito T, Shimazaki Y, Koga T, Tsuzuki M, Ohshima A (2006) Relationship between periodontitis and hepatic condition in Japanese women. J Int Acad Periodontol 8:89–95
Ohyama H, Nakasho K, Yamanegi K, Noiri Y, Kuhara A, Kato-Kogoe N, Yamada N, Hata M, Nishimura F, Ebisu S, Terada N (2009) An unusual autopsy case of pyogenic liver abscess caused by periodontal bacteria. Jpn J Infect Dis 62:381–383
Tomofuji T, Sanbe T, Ekuni D, Azuma T, Irie K, Maruyama T, Tamaki N, Yamamoto T (2008) Oxidative damage of liver induced by ligature-induced periodontitis and chronic ethanol consumption. Arch Oral Biol 53:1113–1118
Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 18:1221–1231
Ludwing J, Viggiano TR, McGill DB, Oh BJ (1980) Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55:434–438
Adams LA, Knuiman MW, Divitini ML, Olynyk JK (2008) Body mass index is a stronger predictor of alanine aminotransaminase levels than alcohol consumption. J Gastroenterol Hepatol 23:1089–1093
Liou I, Kowdley KV (2006) Natural history of nonalcoholic steatohepatitis. J Clin Gastroenterol 40:511–516
Diehl AM, Goodman Z, Ishak KG (1998) Alcohol-like disease in nonalcoholics: a clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 95:1056–1062
Abdelmalek MF, Diehl AM (2007) Nonalcoholic fatty liver disease as a complication of insulin resistance. Med Clin North Am 91:1125–1149
Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini M, Natale S, Vanni E, Villanova N, Melchionda N, Rizzetto M (2003) Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37:917–923
Stefan N, Haring HU (2011) The metabolically benign and malignant fatty liver. Diabetes 60:2011–2017
Samuel VT, Shulman GI (2012) Mechanisms for insulin resistance: common threads and missing links. Cell 148:852–871
Wierzbicki AS, Oben J (2012) Nonalcoholic fatty liver disease and lipids. Curr Opin Lipidol 23:345–352
Bays HE (2011) Adiposopathy is “sick fat” a cardiovascular disease? J Am Coll Cardiol 57:2461–2473
Petersen KF, Oral EA, Dufour S, Befroy D, Ariyan C, Yu C, Cline GW, DePaoli AM, Taylor SI, Gorden P, Shulman GI (2002) Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 109:1345–1350
Tarugi P, Averna M (2011) Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum. Adv Clin Chem 54:81–107
Petersen KF, Dufour S, Hariri A, Nelson-Williams C, Foo JN, Zhang XM, Dziura J, Lifton RP, Shulman GI (2010) Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N Engl J Med 362:1082–1089
Tailleux A, Wouters K, Staels B (2012) Roles of PPARs in NAFLD: potential therapeutic targets. Biochim Biophys Acta 1821:809–818
Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, Boerwinkle E, Cohen JC, Hobbs HH (2008) Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 40:1461–1465
Ye R, Jung DY, Jun JY, Li J, Luo S, Ko HJ, Kim JK, Lee AS (2010) Grp78 heterozygosity promotes adaptive unfolded protein response and attenuates diet-induced obesity and insulin resistance. Diabetes 59:6–16
Stienstra R, Tack CJ, Kanneganti TD, Joosten LA, Netea MG (2012) The inflammasome puts obesity in the danger zone. Cell Metab 15:10–18
Zhang X, Xu A, Chung SK, Cresser JH, Sweeney G, Wong RL, Lin A, Lam KS (2011) Selective inactivation of c-Jun NH2-terminal kinase in adipose tissue protects against diet-induced obesity and improves insulin sensitivity in both liver and skeletal muscle in mice. Diabetes 60:486–495
Bataille AM, Manautou JE (2012) Nrf2: a potential target for new therapeutics in liver disease. Clin Pharmacol Ther 92:340–348
Rolo AP, Teodoro JS, Palmeira CM (2012) Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med 52:59–69
Aldaba-Muruato LR, Moreno MG, Shibayama M, Tsutsumi V, Muriel P (2012) Protective effects of allopurinol against acute liver damage and cirrhosis induced by carbon tetrachloride: modulation of NF-kappaB, cytokine production and oxidative stress. Biochim Biophys Acta 1820:65–75
Ivanov AV, Smirnova OA, Ivanova ON, Masalova OV, Kochetkov SN, Isaguliants MG (2011) Hepatitis C virus proteins activate NRF2/ARE pathway by distinct ROS-dependent and independent mechanisms in HUH7 cells. PLoS ONE 6:e24957
Hagen TM, Huang S, Curnutte J, Fowler P, Martinez V, Wehr CM, Ames BN, Chisari FV (1994) Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc Natl Acad Sci U S A 91:12808–12812
Furuta M, Ekuni D, Yamamoto T, Irie K, Koyama R, Sanbe T, Yamanaka R, Morita M, Kuroki K, Tobe K (2010) Relationship between periodontitis and hepatic abnormalities in young adults. Acta Odontol Scand 68:27–33
Jaiswal G, Deo V, Bhongrade M, Jaiswal S (2011) Serum alkaline phosphatase: a potential marker in the progression of periodontal disease in cirrhosis patients. Quintessence Int 42:345–348
Louthan MV, Theriot JA, Zimmerman E, Stutts JT, McClain CJ (2005) Decreased prevalence of nonalcoholic fatty liver disease in black obese children. J Pediatr Gastroenterol Nutr 41:426–429
Tamaki N, Takaki A, Tomofuji T, Endo Y, Kasuyama K, Ekuni D, Yasunaka T, Yamamoto K, Morita M (2011) Stage of hepatocellular carcinoma is associated with periodontitis. J Clin Periodontol 38:1015–1020
Feingold KR, Staprans I, Memon RA, Moser AH, Shigenaga JK, Doerrler W, Dinarello CA, Grunfeld C (1992) Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J Lipid Res 33:1765–1776
Tomofuji T, Ekuni D, Yamanaka R, Kusano H, Azuma T, Sanbe T, Tamaki N, Yamamoto T, Watanabe T, Miyauchi M, Takata T (2007) Chronic administration of lipopolysaccharide and proteases induces periodontal inflammation and hepatic steatosis in rats. J Periodontol 78:1999–2006
Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:1761–1772
Saito T, Hayashida H, Furugen R (2007) Metabolic endotoxemia initiates obesity and insulin resistance: diabetes. Diabetes 56:1761–1772, Comment on: Cani et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:1761–1772
Yoneda M, Naka S, Nakano K, Wada K, Endo H, Mawatari H, Imajo K, Nomura R, Hokamura K, Ono M, Murata S, Tohnai I, Sumida Y, Shima T, Kuboniwa M, Umemura K, Kamisaki Y, Amano A, Okanoue T, Ooshima T, Nakajima A (2012) Involvement of a periodontal pathogen, porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease. BMC Gastroenterol 12:16
Furusho H, Miyauchi M, Hyogo H, Inubushi T, Ao M, Ouhara K, Hisatune J, Kurihara H, Sugai M, Hayes CN, Nakahara T, Aikata H, Takahashi S, Chayama K, Takata T (2013) Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice. J Gastroenterol 48:1259–1270
Yamamoto T, Tomofuji T, Tamaki N, Ekuni D, Azuma T, Sanbe T (2010) Effects of topical application of lipopolysaccharide and proteases on hepatic injury induced by high-cholesterol diet in rats. J Periodontal Res 45:129–135
Schwartz J, Stinson FL, Parker RB (1972) The passage of tritiated bacterial endotoxin across intact gingival crevicular epithelium. J Periodontol 43:270–276
Solga SF, Diehl A (2003) Non-alcoholic fatty liver disease: limen-liver interactions and possible role for probiotics. J Hepatol 38:681–687
Amano A, Nakagawa I, Kataoka K, Morisaki I, Hamada S (1999) Distribution of porphyromonas gingivalis strains with fimA genotypes in periodontitis patients. J Clin Microbiol 37:1426–1430
Nakagawa I, Amano A, Ohara-Nemoto Y, Endoh N, Morisaki I, Kimura S, Kawabata S, Hamada S (2002) Identification of a new variant of fimA gene of porphyromonas gingivalis and its distribution in adults and disabled populations with periodontitis. J Periodontal Res 37:425–432
Nelson RG, Shlossman M, Budding LM, Pettitt DJ, Saad MF, Genco RJ, Knowler WC (1990) Periodontal disease and NIDDM in Pima Indians. Diabetes Care 13:836–840
Sconyers JR, Crawford JJ, Moriarty JD (1973) Relationship of bacteremia to tooth brushing in patients with periodontitis. J Am Dent Assoc 87:616–622
Carroll GC, Sebor RJ (1980) Dental flossing and its relationship to transient bacteremia. J Periodontol 51:691–692
Forner L, Larsen T, Kilian M, Holmstrup P (2006) Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. J Clin Periodontol 33:401–407
Steel DM, Whitehead AS (1994) The major acute phase reactant: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 15:81–88
Chitsazi MT, Pourabbas R, Shirmohammadi A, Ahmadi Zenouz G, Vatankhah AH (2008) Association of periodontal diseases with elevation of serum C-reactive protein and body mass index. J Dent Res Dent Clin Dent Prospects 2:9–14
Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E (2001) Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 72:1221–1227
Bain JL, Lester SR, Henry WD, Bishop CM, Turnage AA, Naftel JP, Johnson RB (2009) Comparative gender differences in local and systemic concentrations of pro-inflammatory cytokines in rats with experimental periodontitis. J Periodontal Res 44:133–140
Pussinen PJ, Tuomisto K, Jousilahti P, Havulinna AS, Sundvall J, Salomaa V (2007) Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arterioscler Thromb Vasc Biol 27:1433–1439
Ebersole JL, Cappelli D, Mott G, Kesavalu L, Holt SC, Singer RE (1999) Systemic manifestations of periodontitis in the non-human primate. J Periodontal Res 34:358–362
Lamster IB, Novak MJ (1992) Host mediators in gingival crevicular fluid: implications for the pathogenesis of periodontal disease. Crit Rev Oral Biol Med 3:31–60
Ranney RR (1991) Immunologic mechanisms of pathogenesis in periodontal disease: an assessment. J Periodontal Res 26:243–254
Kinane DF, Adonogianaki E, Moughal N, Winstanley FP, Mooney J, Thornhill M (1991) Immunocytochemical characteristics of cellular infiltrate, related endothelial changes and determination of GCF acute-phase proteins during human experimental gingivitis. J Periodontal Res 26:286–288
Page RC (1991) The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res 26:230–242
Tomofuji T, Azuma T, Kusano H, Sanbe T, Ekuni D, Tamaki N, Yamamoto T, Watanabe T (2006) Oxidative damage of periodontal tissue in the rat periodontitis model: effects of a high-cholesterol diet. FEBS Lett 580:3601–3604
Maruyama T, Tomofuji T, Endo Y, Irie K, Azuma T, Ekuni D, Tamaki N, Yamamoto T, Morita M (2011) Supplementation of green tea catechins in dentifrices suppresses gingival oxidative stress and periodontal inflammation. Arch Oral Biol 56:48–53
Tomofuji T, Ekuni D, Irie K, Azuma T, Tamaki N, Maruyama T, Yamamoto T, Watanabe T, Morita M (2011) Relationships between periodontal inflammation, lipid peroxide and oxidative damage of multiple organs in rats. Biomed Res 32:343–349
Karaağaç N, Salman F, Doğru-Abbasoğlu S, Uysal M (2011) Changes in prooxidant-antioxidant balance in tissues of rats following long-term hyperglycemic status. Endocr Res 36:124–133
Ekuni D, Endo Y, Irie K, Azuma T, Tamaki N, Tomofuji T, Morita M (2010) Imbalance of oxidative/anti-oxidative status induced by periodontitis is involved in apoptosis of rat submandibular glands. Arch Oral Biol 55:170–176
Nager RM, Salameh F, Reznick AZ, Livshits V, Nahir AM (2003) Salivary gland involvement in rheumatoid arthritis and its relationship to induced oxidative stress. Rheumatology (Oxford) 42:1234–1241
Abdollahi M, Fooladian F, Emami B, Zafari K, Bahreini-Moghadam A (2003) Protection by sildenafil and theophylline of lead acetate-induced oxidative stress in rat submandibular gland and saliva. Hum Exp Toxicol 22:587–592
de la Cal C, Lomniczi A, Mohn CE, De Laurentiis A, Casal M, Chiarenza A, Paz D, McCann SM, Rettori V, Elverdín JC (2006) Decrease in salivary secretion by radiation mediated by nitric oxide and prostaglandins. Neuroimmunomodulation 13:19–27
Tamaki N, Tomofuji T, Ekuni D, Yamanaka R, Yamamoto T, Morita M (2009) Short-term of non-surgical periodontal treatment on plasma level of reactive oxygen metabolites in patients with chronic periodontitis. J Periodontol 80:901–906
Ekuni D, Tomofuji T, Tamaki N, Sanbe H, Azuma T, Yamanaka R, Yamamoto T, Watanabe T (2008) Mechanical stimulation of gingiva reduces plasma 8-OHdG level in rat periodontitis. Arch Oral Biol 53:324–329
Tomofuji T, Ekuni D, Sanbe T, Azuma T, Tamaki N, Irie K, Maruyama T, Yamamoto T, Watanabe T, Miyauchi M, Takata T (2009) Effects of improvement in periodontal inflammation by tooth brushing on serum lipopolysaccharide concentration and liver injury in rats. Acta Odontol Scand 67:200–205
Tamaki N, Tomofuji T, Ekuni D, Yamanaka R, Morita M (2011) Periodontal treatment decreases plasma oxidized LDL level and oxidative stress. Clin Oral Investig 15:953–958
Oz SG, Fentoglu O, Kilicarslan A, Guven GS, Tanrtover MD, Aykac Y, Sozen T (2007) Beneficial effects of periodontal treatment on metabolic control of hypercholesterolemia. South Med 100:686–691
Yamazaki K, Honda T, Oda T, Ueki-Maruyama K, Nakajima T, Yoshie H, Seymour GJ (2005) Effects of periodontal treatment on the C-reactive protein and proinflammatory cytokine levels in Japanese periodontitis patients. J Periodontal Res 40:53–58
Elter JR, Hinderliter AL, Offenbacher S, Beck JD, Caughey M, Brodala N, Madianos PN (2006) The effects of periodontal therapy on vascular endothelial function: a pilot trial. Am Heart J 151:47
Grossi SG, Skrepcinski FB, DeCaro T, Robertson DC, Ho AW, Dunford RG, Genco RJ (1997) Treatment of periodontal disease in diabetes reduces glycated hemoglobin. J Periodontol 68:713–719
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Irie, K., Ekuni, D., Tomofuji, T., Morita, M. (2014). Periodontitis and Liver Diseases. In: Ekuni, D., Battino, M., Tomofuji, T., Putnins, E. (eds) Studies on Periodontal Disease. Oxidative Stress in Applied Basic Research and Clinical Practice. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4614-9557-4_14
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9557-4_14
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4614-9556-7
Online ISBN: 978-1-4614-9557-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)